| College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ... J Clin Oncol 28 (16), 2784-2795, 2010 | 5529 | 2010 |
| American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in … MEH Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ... Journal of Clinical Oncology 28 (16), 2784-2795, 2010 | 4031 | 2010 |
| Steroid‐hormone receptors in breast cancer JL Wittliff Cancer 53 (S3), 630-643, 1984 | 500 | 1984 |
| Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels SL Fitzpatrick, J Brightwell, JL Wittliff, GH Barrows, GS Schultz Cancer research 44 (8), 3448-3453, 1984 | 352 | 1984 |
| Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. B Fisher, C Redmond, A Brown, DL Wickerham, N Wolmark, J Allegra, ... Journal of Clinical Oncology 1 (4), 227-241, 1983 | 344 | 1983 |
| Treatment of primary breast cancer with chemotherapy and tamoxifen B Fisher, C Redmond, A Brown, N Wolmark, J Wittliff, ER Fisher, D Plotkin, ... New England Journal of Medicine 305 (1), 1-6, 1981 | 335 | 1981 |
| Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor–coactivator interactions AM Leduc, JO Trent, JL Wittliff, KS Bramlett, SL Briggs, NY Chirgadze, ... Proceedings of the National Academy of Sciences 100 (20), 11273-11278, 2003 | 307 | 2003 |
| Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 … M Fekete, JL Wittliff, AV Schally Journal of clinical laboratory analysis 3 (3), 137-147, 1989 | 286 | 1989 |
| Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes B Fisher, J Dignam, E Tan-Chiu, S Anderson, ER Fisher, JL Wittliff, ... Journal of the National Cancer Institute 93 (2), 112-120, 2001 | 246 | 2001 |
| Pathogenesis and treatment of infant skin strawberry hemangiomas: clinical and in vitro studies of hormonal effects GH Sasaki, CY Pang, JL Wittliff Plastic and reconstructive surgery 73 (3), 359-368, 1984 | 204 | 1984 |
| Special report. Steriod receptors in breast cancer. ER DeSombre, PP Carbone, EV Jensen, WL McGuire, SA Wells Jr, ... The New England Journal of Medicine 301 (18), 1011-1012, 1979 | 203 | 1979 |
| Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans JL Wittliff, R Hilf, WF Brooks Jr, ED Savlov, TC Hall, RA Orlando Cancer Research 32 (9), 1983-1992, 1972 | 177 | 1972 |
| Prolonging tamoxifen therapy for primary breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial B FISHER, ANN BROWN, N WOLMARK, C REDMOND, DL WICKERHAM, ... Annals of internal medicine 106 (5), 649-654, 1987 | 160 | 1987 |
| Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression G Halmos, JL Wittliff, AV Schally Cancer research 55 (2), 280-287, 1995 | 158 | 1995 |
| Detection and Partial Characterization of Receptors for [d-Trp6]-Luteinizing Hormone-releasing Hormone and Epidermal Growth Factor in Human Endometrial … G Srkalovic, JL Wittliff, AV Schally Cancer research 50 (6), 1841-1846, 1990 | 142 | 1990 |
| Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers CH van Aswegen, RH Purdy, JL Wittliff Journal of steroid biochemistry 32 (4), 485-492, 1989 | 117 | 1989 |
| Interrogating differences in expression of targeted gene sets to predict breast cancer outcome SA Andres, GN Brock, JL Wittliff BMC cancer 13, 1-18, 2013 | 115 | 2013 |
| Practice guidelines and recommendations for use of tumor markers in the clinic M Fleisher, AM Dnistrian, CM Sturgeon, R Lamerz, JL Wittliff Tumor markers: physiology, pathobiology, technology and clinical …, 2002 | 113 | 2002 |
| Potent inhibitors of LXXLL‐based protein–protein interactions AK Galande, KS Bramlett, JO Trent, TP Burris, JL Wittliff, AF Spatola ChemBioChem 6 (11), 1991-1998, 2005 | 110 | 2005 |
| Clinical correlations of steroid receptors and male breast cancer RB Everson, ME Lippman, EB Thompson, WL McGuire, JL Wittliff, ... Cancer Research 40 (4), 991-997, 1980 | 105 | 1980 |
